Clinical Trials Logo

Inflammatory Bowel Diseases clinical trials

View clinical trials related to Inflammatory Bowel Diseases.

Filter by:

NCT ID: NCT00577928 Completed - Clinical trials for Inflammatory Bowel Disease

Value of Fecal Calprotectin

Start date: April 2006
Phase: N/A
Study type: Observational

For the main goal - the accuracy of calprotectin for the diagnosis of IBD - calprotectin levels will be compared between patients with and without a diagnosis of IBD and the sensitivity, specificity and accuracy will be determined. For the secondary aim - the correlation between calprotectin levels and disease activity - in patients with IBD selected from this cohort, we will determine the association between calprotectin levels and clinical IBD score, serological markers (WBC, Hgb, Platelets, ESR, CRP, Albumin), endoscopic (disease score, pathological activity) and radiological features (bowel wall thickening, enhancement, edema, mesenteric inflammation).

NCT ID: NCT00577538 Completed - Lymphoma Clinical Trials

Prevalence of Lymphoma in IBD

Start date: April 2006
Phase: N/A
Study type: Observational

Patients with inflammatory bowel disease (IBD) may be at increased risk of lymphoma. The majority of lymphomas in patients with IBD occur in areas of active inflammation. The relationship between IBD and lymphoproliferative disease is however unclear, since both chronic inflammation as well as medications used to treat IBD (especially immunosuppressives - Azathioprine or 6-MP - and anti-TNF alpha agents) have been associated with increased risk of lymphoma. We plan to study the association between IBD and lymphoma in a large, mixed, community based and referral population from the IBD database at Indiana University.

NCT ID: NCT00574028 Completed - Clinical trials for Inflammatory Bowel Disease

Inflammatory Bowel Disease Research Registry

Start date: August 2007
Phase: N/A
Study type: Observational

The objective and aims of this study is to develop The University of California Irvine Medical Center Inflammatory Bowel Disease Research Registry for the purpose of: 1. Performance of retrospective studies on inflammatory bowel disease to assess disease outcomes and response to therapy. 2. Obtaining permission from the Research Registry participants to be contacted by members of The University of California Irvine Medical Center Inflammatory Bowel Disease Research Center to identify patients that may be eligible for participation in future research studies. 3. Performance of studies to quantify disease phenotypes and treatment patterns.

NCT ID: NCT00567593 Completed - Clinical trials for Inflammatory Bowel Disease

Gene Regulation by Thiazolidinediones

GReaT
Start date: October 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the effect of rosiglitazone on the genes of the colon

NCT ID: NCT00542776 Completed - Clinical trials for Inflammatory Bowel Disease (IBD)

Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine

Start date: October 2007
Phase: N/A
Study type: Observational

The purpose of this study is to compare the efficacy and safety of influenza vaccine in patients with inflammatory bowel disease (IBD) on immunosuppressive therapy with IBD patients on aminosalicylates and healthy historical controls.

NCT ID: NCT00534911 Completed - Depression Clinical Trials

Reducing Depressive Symptoms in Physically Ill Youth

Start date: September 2007
Phase: N/A
Study type: Interventional

Children and adolescents with inflammatory bowel disease (IBD) have high rates of depressive symptoms and more trouble with daily functioning than those without physical illness. The proposed study will investigate if cognitive behavioral therapy (CBT) is better than supportive therapy (SNDT) in reducing emotional distress and improving functioning in youth ages 9-17 with Crohn's disease or Ulcerative Colitis and depression. This study will also assess the effect of CBT on IBD-related factors such as disease severity, medication adherence, and physical-health related quality of life. Hypothesis - Individuals who receive CBT will show more improvement than individuals who receive SNDT.

NCT ID: NCT00521950 Completed - Ulcerative Colitis Clinical Trials

Cost-effectiveness of TPMT Pharmacogenetics

TOPIC
Start date: September 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether thiopurine S-methyltransferase (TPMT) genotyping prior to thiopurine use is cost-effective in patients with inflammatory bowel disease (IBD) in need of immune suppression. The study is designed to test the hypothesis that optimization of initial thiopurine dose based on pre-treatment TPMT genotyping will maximize treatment efficacy and minimize adverse drug reactions (ADRs) resulting in reduced costs.

NCT ID: NCT00516776 Completed - Ulcerative Colitis Clinical Trials

The Innate Immune System and Inflammatory Bowel Disease

Start date: June 2007
Phase: N/A
Study type: Observational

The study includes individuals with ulcerative colitis, Crohn's disease and healthy controls. The purpose of this study is to examine the innate immune system (IIS) by exposing peripheral blood monocytes to various ligands relevant for stimulation of the IIS and study the immune response. Colonic mucosal samples are examined to find gene expression patterns which may distinguish the two forms of disease from each other and from healthy controls. The hypothesis is that the innate immune system has responses unique for the disease states, and that the diseases may be differentiated by examination of gene expression patterns in mucosal biopsies.

NCT ID: NCT00486031 Completed - Ulcerative Colitis Clinical Trials

Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study

Start date: October 2006
Phase: Phase 3
Study type: Interventional

The objective of the study is to evaluate the long-term safety and tolerability of treatment with balsalazide disodium tablets in subjects who are in remission from ulcerative colitis or who have mildly to moderately active UC.

NCT ID: NCT00475410 Completed - Anal Fistula Clinical Trials

Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease

FATT1
Start date: February 2007
Phase: Phase 3
Study type: Interventional

Anal fistula is defined as an abnormal communication between the anal canal and the perianal skin. Adipose-derived stem cells are a new therapy for the closure of these fistulas. This study will test the safety and efficacy of ASCs (adipose stem cells) in the treatment of patients without Crohn´s disease.